Published in Free Radic Biol Med on March 15, 2000
The chemistry and biology of nitroxide compounds. Free Radic Biol Med (2007) 2.76
Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev (2008) 1.91
Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc Natl Acad Sci U S A (2001) 1.89
Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther (2010) 1.66
A mitochondria-targeted triphenylphosphonium-conjugated nitroxide functions as a radioprotector/mitigator. Radiat Res (2009) 1.26
Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent. J Cereb Blood Flow Metab (2008) 1.06
Intraesophageal administration of GS-nitroxide (JP4-039) protects against ionizing irradiation-induced esophagitis. In Vivo (2010) 1.05
Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene. Hum Gene Ther (2008) 1.04
HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer. Cancer Res (2014) 1.00
Mitochondrial targeting of a catalase transgene product by plasmid liposomes increases radioresistance in vitro and in vivo. Radiat Res (2009) 0.99
Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: differential cytotoxicity in healthy and cancer cells. Free Radic Biol Med (2010) 0.97
Modulation of radiation-induced life shortening by systemic intravenous MnSOD-plasmid liposome gene therapy. Radiat Res (2008) 0.96
Oxidative stress imaging in live animals with techniques based on electron paramagnetic resonance. Radiat Res (2012) 0.86
Treatment of Radiation Injury. Adv Wound Care (New Rochelle) (2014) 0.82
In vivo evaluation of different alterations of redox status by studying pharmacokinetics of nitroxides using magnetic resonance techniques. Redox Biol (2015) 0.81
Amelioration of radiation esophagitis by orally administered p53/Mdm2/Mdm4 inhibitor (BEB55) or GS-nitroxide. In Vivo (2011) 0.80
A new chiral pyrrolyl α-nitronyl nitroxide radical attenuates β-amyloid deposition and rescues memory deficits in a mouse model of Alzheimer disease. Neurotherapeutics (2013) 0.77
Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. Chem Rev (2017) 0.76
Nitroxide pharmaceutical development for age-related degeneration and disease. Front Genet (2015) 0.75
A Novel Nitronyl Nitroxide with Salicylic Acid Framework Attenuates Pain Hypersensitivity and Ectopic Neuronal Discharges in Radicular Low Back Pain. Neural Plast (2015) 0.75
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res (1987) 10.80
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med (1998) 3.51
Creating organized delivery systems: the barriers and facilitators. Hosp Health Serv Adm (1993) 2.88
Patient outcomes in alternative long-term care settings. Med Care (1978) 2.83
Hygiene's competitive challenge to dentistry. J Can Dent Assoc (1997) 2.67
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res (1987) 2.56
Conceptualizing and measuring integration: findings from the health systems integration study. Hosp Health Serv Adm (1993) 2.48
Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci U S A (1993) 2.39
Physician-induced demand for surgery. J Health Econ (1986) 2.32
Induction of B2 RNA polymerase III transcription by heat shock: enrichment for heat shock induced sequences in rodent cells by hybridization subtraction. Nucleic Acids Res (1986) 2.31
The multifaceted roles of nitric oxide in cancer. Carcinogenesis (1998) 2.19
The hidden mental health network. Treatment of mental illness by nonpsychiatrist physicians. Arch Gen Psychiatry (1985) 2.17
Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med (1995) 2.14
Sources of hospital cost variation by urban-rural location. Med Care (1987) 2.05
Viability measurements in mammalian cell systems. Anal Biochem (1989) 2.03
A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care (2000) 1.94
Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chem Res Toxicol (1995) 1.90
On the spin trapping and ESR detection of oxygen-derived radicals generated inside cells. Proc Natl Acad Sci U S A (1986) 1.72
Biologically active metal-independent superoxide dismutase mimics. Biochemistry (1990) 1.72
Protein folds and functions. Structure (1998) 1.69
Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest (1983) 1.59
Do nitroxide antioxidants act as scavengers of O2-. or as SOD mimics? J Biol Chem (1996) 1.59
Learning by doing in CABG surgery. Med Care (1990) 1.56
Protein recognition of adenylate: an example of a fuzzy recognition template. J Mol Biol (1996) 1.54
Physician behavior under the Medicare assignment option. J Health Econ (1982) 1.54
Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci U S A (1992) 1.54
Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. Arch Biochem Biophys (1991) 1.53
The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch Biochem Biophys (1998) 1.49
The usefulness of a predictive instrument to reduce inappropriate admissions to the coronary care unit. Ann Intern Med (1980) 1.45
In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst (1994) 1.45
Effects of repeated days of intensified training on muscle glycogen and swimming performance. Med Sci Sports Exerc (1988) 1.41
Why do women physicians work fewer hours than men physicians? Inquiry (1984) 1.40
An unusual case of postoperative hoarseness. Anaesthesia (1992) 1.39
Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem (1997) 1.37
Implementing organized delivery systems: an integration scorecard. Health Care Manage Rev (1994) 1.37
The Medicare physician fee freeze: what really happened? Health Aff (Millwood) (1989) 1.36
In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. Cancer Res (1983) 1.36
Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer (1988) 1.35
Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res (1992) 1.34
Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J Biol Chem (1996) 1.33
Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br J Cancer (1993) 1.30
Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res (1986) 1.27
In vivo imaging of a stable paramagnetic probe by pulsed-radiofrequency electron paramagnetic resonance spectroscopy. Magn Reson Med (1997) 1.26
The effects of neonatal handling on the development of the adrenocortical response to stress: implications for neuropathology and cognitive deficits in later life. Psychoneuroendocrinology (1991) 1.26
Convenient colorimetric and fluorometric assays for S-nitrosothiols. Anal Biochem (1996) 1.25
Parallel coil resonators for time-domain radiofrequency electron paramagnetic resonance imaging of biological objects. J Magn Reson (2000) 1.23
In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. Cancer Res (1998) 1.23
Access to private obstetrics/gynecology services under Medicaid. Med Care (1984) 1.23
Mastectomy or conservation for early breast cancer: psychological morbidity. Eur J Cancer (1992) 1.22
Physician DRGs. N Engl J Med (1985) 1.22
Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr Top Cell Regul (1996) 1.18
Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res (1993) 1.17
Potential use of nitroxides in radiation oncology. Cancer Res (1994) 1.17
Medicaid participation by medical and surgical specialists. Med Care (1983) 1.17
Covering uninsured adults through Medicaid: lessons from the Oregon health plan. Health Care Financ Rev (2000) 1.16
In vivo radiation protection by nitric oxide modulation. Cancer Res (1994) 1.13
Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. Nitric Oxide (1997) 1.11
Is Smad3 a major player in signal transduction pathways leading to fibrogenesis? Chest (2001) 1.11
Three-dimensional whole body imaging of spin probes in mice by time-domain radiofrequency electron paramagnetic resonance. Magn Reson Med (2000) 1.11
An economic model of large Medicaid practices. Health Serv Res (1984) 1.10
Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol (1989) 1.10
Direct and indirect effects of nitric oxide in chemical reactions relevant to biology. Methods Enzymol (1996) 1.10
High-speed data acquisition system and receiver configurations for time-domain radiofrequency electron paramagnetic resonance spectroscopy and imaging. J Magn Reson (1999) 1.09
Glutathione elevation during thermotolerance induction and thermosensitization by glutathione depletion. Cancer Res (1983) 1.09
Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J Rheumatol (1999) 1.08
Radiation-induced cellular reproductive death and chromosome aberrations. Radiat Res (1978) 1.07
Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol (1996) 1.07
Evaluation of tempol radioprotection in a murine tumor model. Free Radic Biol Med (1997) 1.06
Evaluation of commercial vancomycin agar screen plates for detection of vancomycin-resistant enterococci. J Clin Microbiol (1996) 1.06
Nitric oxide (NO) protects against cellular damage by reactive oxygen species. Toxicol Lett (1995) 1.05
Cremophor EL, solvent for paclitaxel, and toxicity. Lancet (1993) 1.05
The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection. Arch Biochem Biophys (1996) 1.05
Rapid detection of cytomegalovirus in clinical specimens by immunofluorescent staining of shell vial cultures. Am J Clin Pathol (1988) 1.05
Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs. Int J Radiat Oncol Biol Phys (1987) 1.04
Biology of chronic radiation effect on tissues and wound healing. Clin Plast Surg (1993) 1.04
Threshold dose for peripheral neuropathy following intraoperative radiotherapy (IORT) in a large animal model. Int J Radiat Oncol Biol Phys (1991) 1.03
The importance of peroxide and superoxide in the X-ray response. Int J Radiat Oncol Biol Phys (1992) 1.03
Can price controls induce optimal physician behavior? J Health Polit Policy Law (1989) 1.02
Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-kappaB. Head Neck (2000) 1.01
Sensitivity to chemical oxidants and radiation in CHO cell lines deficient in oxidative pentose cycle activity. Int J Radiat Oncol Biol Phys (1992) 1.01
Large medicaid practices and medicaid mills. JAMA (1980) 1.01
Diffusion of new technologies in the treatment of the Medicare population. Implications for patient access and program expenditures. Int J Technol Assess Health Care (1993) 1.01